Prevention of Central Veinous Device Related Sepsis Relapse With Taurolidine in Patients on Parenteral Nutrition in Long-term Home.

Trial Profile

Prevention of Central Veinous Device Related Sepsis Relapse With Taurolidine in Patients on Parenteral Nutrition in Long-term Home.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 04 Mar 2013

At a glance

  • Drugs Taurolidine (Primary)
  • Indications Bacterial infections; Catheter infections; Sepsis
  • Focus Therapeutic Use
  • Acronyms Nutrilock
  • Most Recent Events

    • 01 Dec 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 24 Mar 2010 Planned end date changed from 1 May 2010 to 1 May 2012 as reported by ClinicalTrials.gov.
    • 29 Jan 2008 Status changed from initiated to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top